by GlobeNewsWire | Feb 8, 2016 | Globe Newswire, GNW Alerts
[cmwizard menu=avxlmenu title=”Full Coverage AVXL”/] NEW YORK, Feb. 08, 2016 (GLOBE NEWSWIRE) — Anavex Life Sciences Corp. (“Anavex” or the “Company”) (Nasdaq:AVXL), a clinical-stage biopharmaceutical company developing differentiated therapeutics...
by GlobeNewsWire | Jan 11, 2016 | Buzz, Globe Newswire, GNW Alerts
[cmwizard menu=avxlmenu title=”Full Coverage AVXL”/] NEW YORK, Jan. 11, 2016 (GLOBE NEWSWIRE) — Anavex Life Sciences Corp. (“Anavex” or the “Company”) (Nasdaq:AVXL), a clinical-stage biopharmaceutical company developing differentiated therapeutics...
by GlobeNewsWire | Dec 30, 2015 | Globe Newswire
NEW YORK, Dec. 30, 2015 (GLOBE NEWSWIRE) — Pomerantz LLP announces that a class action lawsuit has been filed against Anavex Life Sciences Corp. (“Anavex” or the “Company”)(NASDAQ:AVXL), and certain of its officers. The class action, filed in United States...
by GlobeNewsWire | Dec 29, 2015 | Globe Newswire
NEW YORK, Dec. 29, 2015 (GLOBE NEWSWIRE) — Anavex Life Sciences Corp. (“Anavex” or the “Company”) (Nasdaq:AVXL), a clinical-stage biopharmaceutical company developing differentiated therapeutics for the treatment of neurodegenerative diseases including...
by GlobeNewsWire | Dec 2, 2015 | Globe Newswire
[cmwizard menu=avxlmenu title=”Full Coverage AVXL”/]NEW YORK, Dec. 02, 2015 (GLOBE NEWSWIRE) — Anavex Life Sciences Corp. (“Anavex” or the “Company”) (Nasdaq:AVXL), a clinical-stage biopharmaceutical company developing drug candidates to treat...
